Related Experiment Video
Updated: May 17, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Defective complement inhibitory function predisposes to renal disease
Anuja Java1, John Atkinson, Jane Salmon
1Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA. AJAVA@dom.wustl.edu
Insights
The complement system significantly impacts human kidney diseases, with genetic mutations and excessive activation leading to conditions like atypical hemolytic uremic syndrome. Understanding these complement pathways enables targeted therapies for renal diseases.
Area of Science:
- Nephrology
- Immunology
- Genetics
Background:
- The complement system's role in renal disease is established in immune-complex disorders and dense deposit disease.
- Recent research highlights complement regulatory gene mutations in thrombotic microangiopathies and preeclampsia.
Purpose of the Study:
- To review the involvement of complement system dysregulation in various human renal diseases.
- To discuss the link between genetic mutations, complement overactivation, and thrombotic microangiopathies.
Main Methods:
- Literature review of complement system's role in renal pathology.
- Analysis of genetic mutations in complement regulatory genes.
- Examination of the procoagulant state induced by complement activation.
Main Results:
- Mutations in complement regulatory genes predispose individuals to thrombotic microangiopathies (e.g., atypical hemolytic uremic syndrome, C3 and C1q glomerulopathies).
- Excessive complement activation on endothelial cells, caused by autoantibodies or protein deficiencies, promotes a procoagulant state.
- These mechanisms are implicated in systemic lupus erythematosus, dense deposit disease, preeclampsia, and antiphospholipid syndrome.
Conclusions:
- Genetic alterations in complement regulatory proteins are key drivers of specific renal diseases.
- Targeted therapies blocking complement activation have emerged based on understanding these genetic and functional consequences.
Abstract:
The role of the complement system in mediating human renal disease has long been recognized in immune-complex excess syndromes such as systemic lupus erythematosus and in dense deposit disease in which no immunoglobulin (Ig) is present. Over the past 15 years, mutations in complement regulatory genes have been demonstrated to predispose to thrombotic microangiopathies including atypical hemolytic uremic syndrome, C3 and C1q glomerulopathies, and preeclampsia. Excessive complement activation on an endothelial cell, due to either an autoantibody or a regulatory protein deficiency, sets up a procoagulant state in these diseases as well as in the antiphospholipid syndrome. Knowledge of the genes involved and the functional consequences of alterations in their structure has led to therapy that blocks complement activation.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Acute Kidney Injury II: Pathophysiology
Nephrons
Diabetic Nephropathy
Chronic Kidney Disease I: Introduction
Nephrotic Syndrome I : Introduction
